|
|
Volumn 195, Issue 3, 2001, Pages 361-366
|
|
p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome
a,c
|
|
Author keywords
Clinical outcome; p53; Peripheral T cell lymphomas; Prognosis
|
|
Indexed keywords
GENE PRODUCT;
GLYCOPROTEIN P;
PROTEIN BCL 2;
PROTEIN MDM2;
PROTEIN P21;
PROTEIN P53;
ANALYSIS;
ARTICLE;
BIOLOGY;
CANCER GRADING;
CANCER INCIDENCE;
CANCER SURVIVAL;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATION FUNCTION;
COST;
DISEASE ASSOCIATION;
EVIDENCE BASED MEDICINE;
GENE OVEREXPRESSION;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE;
MOLECULAR GENETICS;
MULTIDRUG RESISTANCE;
MULTIVARIATE ANALYSIS;
NONHODGKIN LYMPHOMA;
PERIPHERAL LYMPHOCYTE;
PRIORITY JOURNAL;
PROGNOSIS;
T CELL LYMPHOMA;
WESTERN HEMISPHERE;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
KI-67 ANTIGEN;
LYMPHOMA, T-CELL, PERIPHERAL;
MALE;
MIDDLE AGED;
NUCLEAR PROTEINS;
P-GLYCOPROTEIN;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
PROTO-ONCOGENE PROTEINS C-MDM2;
ROC CURVE;
STATISTICS, NONPARAMETRIC;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 0034782531
PISSN: 00223417
EISSN: None
Source Type: Journal
DOI: 10.1002/path.945 Document Type: Article |
|
Times cited : (37)
|
|
References (18)
|
